USA flag logo/image

An Official Website of the United States Government

High-throughput screening and identification of scFv antibodies against…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
96498
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
RR028160
Solicitation Year:
N/A
Solicitation Topic Code:
NCRR
Solicitation Number:
N/A
Small Business Information
AFFOMIX, INC.
AFFOMIX, INC. 52 LEIGHTON TRAIL GUILFORD, CT 06437
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: High-throughput screening and identification of scFv antibodies against glycosyla
Agency: HHS
Contract: 1R43RR028160-01
Award Amount: $193,520.00
 

Abstract:

DESCRIPTION (provided by applicant): The specific goal of this proposal is to develop a high-throughput method to identify scFv antibodies that recognize post-translationally modified proteins. We propose to complete a proof-of-concept for a new type of af finity screening process based on emulsion, secretion, and capture, which we term ESCape . In the proposed phage ESCape method, E. coli transformed with a phagemid encoding an scFv antibody-gpIII fusion library is infected with M13K07-H9 (His6::gpIX) help er phage. The infected bacterium is then compartmentalized along with a cobalt-chelate capture-bead in a water-in-oil (W/O) emulsion. Consequently, in each isolated compartment during overnight incubation, thousands of copies of the recombinant phage dis playing an scFv protein at one end (fused to the gpIII protein) and a his6 peptide at the opposite end (fused to the gpIX protein) are produced (Fig. 1). The his6-end of the display phage will bind to the cobalt-chelate capture-bead. The emulsion will be b roken, and these beads, along with any phage bound to them, will be isolated. The phage-bound beads will be incubated with an Alexa 488-labeled antigen and then washed to remove any unbound ligand. The labeled beads will then be sorted (together with the p hage attached to them) from the population of beads by flow cytometry. Enriched beads can be plated onto a lawn of E. coli and the phagemid-encoded scFv further tested for specificity and affinity. We will compare this phage ESCape method with traditional methods for phage biopanning to identify scFv antibodies that recognize the glycosylated extracellular domain of the c-ErbB2/Her2 protein. The number of specific scFvs identified, their binding affinities, the time and cost associated with the screening me thod, and the ability to automate the assay will be evaluated. PUBLIC HEALTH RELEVANCE: The goal of this proposal is to develop a high-throughput method to identify scFv antibodies that recognize post-translationally modified proteins. A novel metho d is described for amplifying single bacteriophage within an emulsion droplet and subsequently capturing and displaying the phage on the surface of a 3 micron bead. We will apply this phage-based surface display method toward identification of single chain variable fragment (scFv) antibodies that specifically recognize a glycosylated protein. The number of specific scFvs identified, their binding affinities, the time and cost associated with the screening method, and the ability to automate the assay will b e evaluated and compared with traditional phage biopanning.

Principal Investigator:

Margaret M. Kiss

Business Contact:

Michael Weiner
mweiner@affomix.com
Small Business Information at Submission:

AFFOMIX, INC.
AFFOMIX, INC. 688 East Main Street Branford, CT 06405

EIN/Tax ID: 184170700
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No